Targeting the HIV-1 RNA leader sequence with synthetic oligonucleotides and siRNA: chemistry and cell delivery
- PMID: 16337923
- DOI: 10.1016/j.bbamem.2005.10.013
Targeting the HIV-1 RNA leader sequence with synthetic oligonucleotides and siRNA: chemistry and cell delivery
Abstract
New candidates for development as potential drugs or virucides against HIV-1 infection and AIDS continue to be needed. The HIV-1 RNA leader sequence has many essential functional sites for virus replication and regulation that includes several highly conserved sequences. The review describes the historical context of targeting the HIV-1 RNA leader sequence with antisense phosphorothioate oligonucleotides, such as GEM 91, and goes on to describe modern approaches to targeting this region with steric blocking oligonucleotide analogues having newer and more advantageous chemistries, as well as recent studies on siRNA, towards the attainment of antiviral activity. Recent attempts to obtain improved cell delivery are highlighted, including exciting new developments in the use of peptide conjugates of peptide nucleic acid (PNA) as potential virucides.
Similar articles
-
Clinical trial results of GEM91 show activity against advance HIV.AIDS Patient Care STDS. 1997 Aug;11(4):290-1. AIDS Patient Care STDS. 1997. PMID: 11361850 No abstract available.
-
In vivo metabolic profile of a phosphorothioate oligodeoxyribonucleotide.Antisense Nucleic Acid Drug Dev. 1997 Jun;7(3):159-65. doi: 10.1089/oli.1.1997.7.159. Antisense Nucleic Acid Drug Dev. 1997. PMID: 9212906
-
In vitro evidence for a long range pseudoknot in the 5'-untranslated and matrix coding regions of HIV-1 genomic RNA.J Biol Chem. 2002 Feb 22;277(8):5995-6004. doi: 10.1074/jbc.M108972200. Epub 2001 Dec 13. J Biol Chem. 2002. PMID: 11744696
-
Therapeutic potential of aptamer-siRNA conjugates for treatment of HIV-1.BioDrugs. 2012 Dec 1;26(6):393-400. doi: 10.2165/11635350-000000000-00000. BioDrugs. 2012. PMID: 23046156 Free PMC article. Review.
-
Oligonucleotides as inhibitors of human immunodeficiency virus.Curr Opin Mol Ther. 1999 Jun;1(3):323-31. Curr Opin Mol Ther. 1999. PMID: 11713797 Review.
Cited by
-
Nucleic acids-based therapeutics in the battle against pathogenic viruses.Handb Exp Pharmacol. 2009;189(189):243-63. doi: 10.1007/978-3-540-79086-0_9. Handb Exp Pharmacol. 2009. PMID: 19048203 Free PMC article. Review.
-
The Use of Tricyclo-DNA Oligomers for the Treatment of Genetic Disorders.Biomedicines. 2017 Dec 22;6(1):2. doi: 10.3390/biomedicines6010002. Biomedicines. 2017. PMID: 29271929 Free PMC article. Review.
-
Advanced morpholino oligomers: a novel approach to antiviral therapy.Antiviral Res. 2012 Apr;94(1):80-8. doi: 10.1016/j.antiviral.2012.02.004. Epub 2012 Feb 14. Antiviral Res. 2012. PMID: 22353544 Free PMC article. Review.
-
The HIV oligonucleotide database (HIVoligoDB).Database (Oxford). 2017 Jan 1;2017(1):bax005. doi: 10.1093/database/bax005. Database (Oxford). 2017. PMID: 28365729 Free PMC article.
-
HIV-1 drug discovery: targeting folded RNA structures with branched peptides.Org Biomol Chem. 2015 Jun 7;13(21):5848-58. doi: 10.1039/c5ob00589b. Org Biomol Chem. 2015. PMID: 25958855 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials